Clinical Trial Update: UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: a Phase 2 Trial [NA]

View source ↗

Summary

The Phase 2 trial evaluating UNITY-based MR-Linac guided adaptive radiotherapy for glioblastoma multiforme has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Glioblastoma Multiforme | NA | Status: COMPLETED